Portal de Periódicos da CAPES

Procurement and transfusion of human immunodeficiency virus‐positive or untested autologous blood units: issues and concerns: a report prepared by the Autologous Transfusion Committee of the American Association of Blood Banks

1995; Wiley; Volume: 35; Issue: 4 Linguagem: Inglês

10.1046/j.1537-2995.1995.35495216087.x

1537-2995

Roslyn Yomtovían, Christabel Kelly, Arthur Bracey, S. K. McCraney, Stephen W. Renner, Kenneth R. Williamson, Suzan Attar,

Hemoglobinopathies and Related Disorders

TransfusionVolume 35, Issue 4 p. 353-361 Procurement and transfusion of human immunodeficiency virus-positive or untested autologous blood units: issues and concerns: a report prepared by the Autologous Transfusion Committee of the American Association of Blood Banks R. Yomtovian, Corresponding Author R. Yomtovian Roslyn A. Yomtovian, MD, Assistant Professor of Pathology, Case Western Reserve University School of Medicine; and Director, Blood Bank-Transfusion Medicine Service, University Hospitals of Cleveland, Cleveland, OHRoslyn A. Yomtovian, MD, c/o Deanna Hines, AABB, 8101 Glenbrook Road, Bethesda, MD208I4.Search for more papers by this authorC. Kelly, C. Kelly Cynthia Kelly, Esq., General Counsel, Director, Government and Legal Affairs, American Association of Blood Banks, Bethesda, MD 6610B Jupiter Hills Circle, Alexandria, VA 22312.Search for more papers by this authorA. W. Bracey, A. W. Bracey Arthur W. Bracey, MD, Clinical Associate Professor, University of Texas Health Science Center, and Medical Director, Blood Bank and Transfusion Service, St. Luke's Episcopal Hospital, Houston, TX.Search for more papers by this authorS. K. McCraney, S. K. McCraney Sharon K. McCraney, Associate Director of Technical Services, American Red Cross Blood Services, South Carolina Region, Columbia, SC.Search for more papers by this authorS. W. Renner, S. W. Renner Stephen W. Renner, MD, Assistant Professor of Clinical Pathology, University of California, Los Angeles, and Chief of Blood Bank and Hematology Units, Wadsworth VA Medical Center, Los Angeles, CA.Search for more papers by this authorK. R. Williamson, K. R. Williamson Kenneth R. Williamson, MD, Consultant, Department of Transfusion Medicine, Mayo Foundation, Rochester, MN.Search for more papers by this authorS. Attar, S. Attar Safuh Attar, MD, Professor, Division of Thoracic and Cardiovascular Surgery, University of Maryland School of Medicine, Baltimore, MD.Search for more papers by this author R. Yomtovian, Corresponding Author R. Yomtovian Roslyn A. Yomtovian, MD, Assistant Professor of Pathology, Case Western Reserve University School of Medicine; and Director, Blood Bank-Transfusion Medicine Service, University Hospitals of Cleveland, Cleveland, OHRoslyn A. Yomtovian, MD, c/o Deanna Hines, AABB, 8101 Glenbrook Road, Bethesda, MD208I4.Search for more papers by this authorC. Kelly, C. Kelly Cynthia Kelly, Esq., General Counsel, Director, Government and Legal Affairs, American Association of Blood Banks, Bethesda, MD 6610B Jupiter Hills Circle, Alexandria, VA 22312.Search for more papers by this authorA. W. Bracey, A. W. Bracey Arthur W. Bracey, MD, Clinical Associate Professor, University of Texas Health Science Center, and Medical Director, Blood Bank and Transfusion Service, St. Luke's Episcopal Hospital, Houston, TX.Search for more papers by this authorS. K. McCraney, S. K. McCraney Sharon K. McCraney, Associate Director of Technical Services, American Red Cross Blood Services, South Carolina Region, Columbia, SC.Search for more papers by this authorS. W. Renner, S. W. Renner Stephen W. Renner, MD, Assistant Professor of Clinical Pathology, University of California, Los Angeles, and Chief of Blood Bank and Hematology Units, Wadsworth VA Medical Center, Los Angeles, CA.Search for more papers by this authorK. R. Williamson, K. R. Williamson Kenneth R. Williamson, MD, Consultant, Department of Transfusion Medicine, Mayo Foundation, Rochester, MN.Search for more papers by this authorS. Attar, S. Attar Safuh Attar, MD, Professor, Division of Thoracic and Cardiovascular Surgery, University of Maryland School of Medicine, Baltimore, MD.Search for more papers by this author First published: April 1995 https://doi.org/10.1046/j.1537-2995.1995.35495216087.xCitations: 13 6610B Jupiter Hills Circle, Alexandria, VA 22312. Cynthia Kelly, Esq., General Counsel, Director, Government and Legal Affairs, American Association of Blood Banks, Bethesda, MD Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Mintz PD. Participation of HIV-infected patients in autologous blood programs. JAMA 1993; 269: 2892–4. 2 Popovsky MA, Hoff RG. HIV-infected patients participating in autologous blood programs (letter). JAMA 1993; 270: 2181–2. 3 Petz LD, Kleinman S. HIV-infected patients participating in autologous blood programs (letter). JAMA 1993; 270: 2181. 4 Mintz PD. HIV-infected patients participating in autologous blood programs (reply to letter). JAMA 1993; 270: 2182. 5 Silvergleid AJ. Preoperative autologous donation: what have we learned? (editorial). Transfusion 1991; 31: 99–101. 6 American Association of Blood Banks, American Red Cross, and Council of Community Blood Centers, Joint Statement, January 13, 1983. 7 Prevention of acquired immune deficiency syndrome (AIDS): Report of inter-agency recommendations. MMWR Morb Mortal Wkly Rep 1983; 32: 101–4. 8 Blood policy and technology. Office of Technology Assessment, Congress of the United States. OTA-H-260. Washington: Government Printing Office, 1985. 9 Autologous blood transfusions. JAMA 1986; 256: 2378–80. 10 Report submitted to the President of the United States by James D. Watkins, Superintendent of Documents, and Chairman, Presidential Commission on the Human Immunodeficiency Virus Epidemic. Washington: Presidential Commission on the Human Immunodeficiency Virus Epidemic, 1988. 11 National Blood Resource Education Program Expert Panel, National Heart, Lung, and Blood Institute. The use of autologous blood. JAMA 1990; 263: 414–7. 12 Wallace EL, Surgenor DM, Hao HS, An J., Chapman RH, Churchill WH. Collection and transfusion of blood and blood components in the United States, 1989. Transfusion 1993; 33: I39–44. 13 Zuger A., Miles SH. Physicians, AIDS, and occupational risk. Historic traditions and ethical obligations. JAMA 1987; 258: 1924–8. 14 Pellegrino ED. Altruism, self-interest, and medical ethics (editorial). JAMA 1987; 258: 1939–40. 15 Dan BB. Patients without physicians: the new risk of AIDS (editorial). JAMA 1987; 258: 1940. 16 Chambers LA, Kruskall MS. Preoperative autologous blood donation. Transfus Med Rev 1990; 4: 35–46. 17 Sandler SG. Overview. In: SG Sandler, AJ Silvergleid, eds. Autologous transfusion. Arlington: American Association of Blood Banks, 1983; 1–9. 18 American Association of Blood Banks, American Red Cross, Council of Community Blood Centers. Circular of Information for the Use of Human Blood and Blood Components, 1994 (revised periodically). 19 Thurer RL, Hauer JM. Autotransfusion and blood conservation. Curr Probl Surg 1982; 19: 97–156. 20 Williamson KR, Taswell HF. Avoiding the hazards of homologous blood transfusion, and other advantages of autologous blood transfusion and hemotherapy. In: HF Taswell, AA Pineda, eds. Autologous transfusion and hemotherapy. Boston: Blackwell, 1991; 22–52. 21 Murphy WG. Adverse effects and complications of transfusion. In: G. Rock, MJ Seghachian, eds. Quality assurance in transfusion medicine, vol 2. Boca Raton, CRC Press, 1992; 443–69. 22 J. Lederberg, RE Shope, SC Oaks, eds. Emerging infections—microbial threats to health in the United States. Washington: Institute of Medicine, National Academy Press, 1992: 32. 23 Sire JM, Michelet C., Mesnard R., et al. Septic shock due to Yersinia enterocolitica after autologous transfusion (letter). Clin Infect Dis 1993; 17: 954–5. 24 Richards C., Kolins J., Trindade CD. Autologous transfusion-transmitted Yersinia enterocolitica (letter). JAMA 1992; 268: 154. 25 Linden JV, Kaplan HS. Transfusion errors: causes and effects. Transfus Med Rev 1994: 8: 169–83. 26 Birkmeyer JD, Goodnough LT, AuBuchon JP, Noordsij PG, Littenberg B. The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion 1993; 33: 544–51. 27 Bove JR. Too much of a good thing? (editorial). Transfusion 1993; 33: 542. 28 Birkmeyer JD, AuBuchon JP, Littenberg B., et al. Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. Ann Thorac Surg 1994; 57: 161–8, discussion 168–9. 29 McCullough J. The nation's changing blood supply system. JAMA 1993; 269: 2239–45. 30 Etchason J., Calhoun L., Petz LD, Snider C., Fink A., Kleinman S. Cost effectiveness analysis of a predeposited autologous donation (PAD) program (abstract). Blood 1993; 82(Suppl l): 394a. 31 Blumberg N., Kirkley S., Panzer R., Heal J. A cost analysis of autologous transfusions in hip replacement surgery (abstract). Blood 1993; 82(Suppl 1): 587a. 32 Healy JC, Frankforter SA, Graves BK, Reddy RL, Beck JR. Preoperative autologous blood donation in total-hip arthroplasty. A cost-effectiveness analysis. Arch Pathol Lab Med 1994; 118: 465–70. 33 Kruskall MS, Yomtovian R., Dzik WH, Friedman KD, Umlas J. On improving the cost-effectiveness of autologous transfusion practices. Transfusion 1994; 34: 259–64. 34 Goldfinger D., Haimowitz M. Controversies in transfusion medicine: Is autologous blood transfusion worth the cost. Pro Transfusion 1994; 34: 75–8. 35 AuBuchon JP, Birkmeyer JD. Controversies in transfusion medicine: Is autologous blood transfusion worth the cost. Con Transfusion 1994; 34: 79–83. 36 Resolution no. 1 17: Autologous transfusions for elective surgery. American Medical Association, Proceedings of the House of Delegates, Forty-second interim meeting, Dallas, Texas, Dec. 4–7, 1988. Chicago: American Medical Association, 1988: 278. 37 Yomtovian R., Kruskall MS, Barber JP. Autologous blood transfusion: the reimbursement dilemma. J Bone Joint Surg [Am] 1992; 74: 1265–72. 38 Social Security Act ŝ 1862(a)(1)(A); see at 42 U.S.C. 1 395y-(a)(1)(A). 39 Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S., Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. J Acquir Immune Defic Syndr 1993; 6: 602–10. 40 Skolnik P., Kosloff BR, Hirsch MS. Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. J Infect Dis 1988; 157: 508–14. 41 Lefrere JJ, Mariotti M., Thauvin M. B 19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates. Lancet 1994; 343: 211–2. 42 Naides SJ, Howard EJ, Swack NS, True CA, Stapleton JT. Parvovirus B 19 infection in human immunodeficiency virus type 1 -infected persons failing or intolerant to zidovudine therapy. J Infect Dis 1993; 168: 101–5. 43 Schattner N., Hanuka B., Sarov B., Sarov I., Handzel Z., Bentwich Z. Sequential serological studies of homosexual men with and without HIV infection. Epstein-Barr virus activation preceding and following HIV seroconversion. Clin Exp Immunol 1991; 85: 209–13. 44 Eyster EM, Fried MW, Di Bisceglie AM, Goedert JJ. Increas- ing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Blood 1994; 84: 1020–3. 45 Greene WC. The molecular biology of human immunodeficiency virus type I infection. N Engl J Med 1991; 324: 308–17. 46 Rosenberg ZF, Fauci AS. Activation of latent HIV infection. J NIH Res 1990; 2: 41–5. 47 Schechter M., Harrison LH, Halsey NA, et al. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. JAMA 1994; 271: 353–7. 48 Webster A. Cytomegalovirus as a possible cofactor in HIV disease progression. J Acquir Immune Defic Syndr 1991; 4(Suppl I): S47–S52. 49 Eskild A., Magnus P., Petersen G., et al. Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS 1992; 6: 571–4. 50 Knox KK, Carrigan DR. Disseminated active HHV-6 infections in patients with AIDS. Lancet 1994; 343: 577–8. 51 Lusso P., Gallo RC. Human herpesvirus 6 in AIDS (editorial). Lancet 1994; 343: 555–6. 52 Busch MP, Lee TH, Heitman J. Allogeneic leucocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients. Blood 1992; 80: 2128–35. 53 Blumberg N., Heal JM. Evidence for plasma-mediated immunomodulation—transfusions of plasma-rich blood components are associated with a greater risk of acquired immunodeficiency syndrome than transfusions of red blood cells alone. Transplant Proc 1988; 20: 1138–42. 54 Vamvakas E., Kaplan HS. Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital. Transfusion 1993; 33: 111–8. 55 Sloand E., Kumar P., Klein HG, Merritt S., Sacher R. Transfusion of blood components to persons infected with human immunodeficiency virus type 1: relationship to opportunistic infection. Transfusion 1994; 34: 48–53. 56 Graham NM, Zeger SL, Park LP, et al. The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med 1992; 326: 1037–42. 57 Balfour HH. Transfusion and human immunodeficiency virus (editorial). Transfusion 1993; 33: 101–2. 58 Ethical issues involved in the growing AIDS crisis. Council on Ethical and Judicial Affairs. JAMA 1988; 259: 1360–1. 59 The acquired immunodeficiency syndrome (AIDS) and infection with the human immunodeficiency virus (HIV). Health and Public Policy Committee, American College of Physicians, and the Infectious Diseases Society of America. Ann Intern Med 1988; 108: 460–9. 60 Clarke OW, Conley RB. The duty to “attend upon the sick.” JAMA 1991; 266: 2876–7. 61 American Medical Association. Digest of HIV/AIDS policy. Chicago: American Medical Association, 1993. 62 Human immunodeficiency virus (HIV) infection. American College of Physicians and Infectious Diseases Society of America. Ann Intern Med 1994; 120: 310–9. 63 Parkman PD. Guidance for autologous blood and blood components. Rockville: Food and Drug Administration, March 15, 1989. 64 Parkman PD. Autologous blood collection and processing procedures. Rockville: Food and Drug Administration, February 12, 1990. 65 Dzik WH, Devarajan S. Should autologous blood that tests positive for infectious diseases be used or discarded? A decision analysis approach. Transfusion 1989; 29: 743–5. 66 Renner SW, Howanitz PJ, Bachner P. Wristband identification error reporting in 712 hospitals. A College of American Pathologists' Q-Probes study of quality issues in transfusion practice. Arch Pathol Lab Med 1993; 117: 573–7. 67 Linden JV, Paul B., Dressler KP. A report of 104 transfusion errors in New York State. Transfusion 1992; 32: 601–6. 68 Simpson MB, Georgopoulos G., Orsini E., Eilert RE. Autologous transfusions for orthopedic procedures at a children's hospital. J Bone Joint Surg [Am] 1992; 74: 652–8. 69 Comprehensive transfusion medicine survey, set J-C. Northfield, IL: College of American Pathologists. 1992. 70 Shulman I. Your worst transfusion nightmares. Presented at an American Society of Clinical Pathologists workshop, Orlando, FL, Oct. 16, 1993. 71 Linden J. Autologous blood errors and incidents (abstract). Transfusion 1994; 34(Suppl): 28S. 72 Blood Products Advisory Committee, Center for Biologies Evaluation and Research, Food and Drug Administration, Public Health Service, Department of Health and Human Services. Meeting Transcript, 44th meeting, June 21, 1994; 68–159. Available by writing to: Freedom of Information Office, HFI-35, Food and Drug Administration, 5600 Fishers Lane, Room 12A-16, Rockville, MD 20857. 73 Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I. N Engl J Med 1991; 324: 370–6. 74 Leape LL, Brennan TA, Laird N., et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324: 377–84. 75 Zuck TF. Greetings—a final look back with comments about a policy of a zero-risk blood supply (editorial). Transfusion 1987; 27: 447–8. 76 Baele PL, de Bruyere M., Deneys V., et al. Bedside transfusion errors. A prospective survey by the Belgium SAnGUIS group. Vox Sang 1994; 66: 117–21. 77 Draft guideline for quality assurance in blood establishments (Docket No. 91N-0450). Bethesda: Center for Biologics Evaluation and Research, Food and Drug Administration, US Dept of Health and Human Services, June 17, 1993. 78 Myhre BA. Crossing over of autologous and directed donor blood. Ann Clin Lab Sci 1992; 22: 343–52. 79 Kruskall MS, Glazer EE, Leonard SS, et al. Utilization and effectiveness of a hospital autologous preoperative blood donor program. Transfusion 1986; 26: 335–40. 80 Renner SW, Howanitz PJ, Bachner P. Preoperative autologous blood donation in 612 hospitals. A College of American Pathogists' Q-Probes study of quality issues in transfusion practice. Arch Pathol Lab Med 1992; 116: 613–9. 81 Yawn DH. Autologous blood donation programs. In: G. Rock, MJ Seghatchian, eds. Quality assurance in transfusion medicine, vol I. Boca Raton, FL: CRC Press, 1992; 135–56. 82 Guidelines for autologous transfusion. I. Pre-operative autologous donation. British Committee for Standards in Haematology Blood Transfusion Task Force; Autologous Transfusion Working Party of the NBTS. Transfus Med 1993; 3: 307–16. 83 Yomtovian RA, Schrank JY, Betts YM, Kepner JL. Transfusion of previously donated autologous blood in a community hospital. In: AA Pineda, HF Taswell, eds. Autologous transfusion and hemotherapy. Boslon: Blackwell, 1991; 78–93. 84 Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990; 30: 583–90. 85 Dodd RY. The risk of transfusion-transmitted infection (editorial). N Engl J Med 1992; 327: 369–73. 86 Daniels N. HIV-infected professionals, patienl rights, and the “swilching dilemma.” JAMA 1992; 267: 1368–71. 87 Gambino R. Most laboratory errors are system dependent—not people dependent (editorial). Lab Med 1989; 20: 123. 88 Taswell HF, Galbreath JL, Harmsen WS. Errors in transfusion medicine. Detection, analysis, frequency, and prevention. Arch Pathol Lab Med 1994; 118: 405–10. 89 Wenz B., Burns ER. Improvement in transfusion safety using a new blood unit and patient identification system as part of safe transfusion practice. Transfusion 1991; 31: 401–3. 90 Taswell HF. It's in the bag (or is it?) (editorial). Transfusion 1991; 31: 386–7. 91 Popovsky MA, Moore SB, Wick MR, et al. A blood bank consultation service: principles and practice. Mayo Clin Proc 1985; 60: 312–4. 92 Shulman IA, Lohr K., Derdiarian AK, Picukaric JM. Monitoring transfusionist practices: a strategy for improving transfusion safety. Transfusion 1994; 34: 11–5. 93 Kasprisin CA. Auditing into compliance (editorial). Transfusion 1994; 34: 5–6. 94 Glantz LH, Mariner WK, Annas GJ. Risky business: setting public health policy for HIV-infected health care professionals. Milbank Q 1992; 70: 43–79. 95 Recommendations for prevention of HIV transmission in health-care settings. MMWR Morb Mortal Wkly Rep 1987; 36(Suppl2S): 2S–18S. 96 Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other bloodborne pathogens in health-care settings. MMWR Morb Mortal Wkly Rep 1988; 37: 377–88. 97 Occupational exposure to bloodborne pathogens: final rule (29CFR 1910.1030). Federal Register 1991; 64175–64182. 98 Borowshy EA. Donor and employee safety. In: C. Kasprisin, B. Laird-Fryer, eds. Blood donor collection practices. Bethesda: American Association of Blood Banks, 1993; 25–40. 99 Starkey JM, MacPherson JL, Bolgiano DC, Simon ER, Zuck TF, Sayers MH. Markers for transfusion-transmitted disease in different groups of blood donors. JAMA 1989; 262: 3452–4. 100 Petersen LR, Doll LS. Human immunodeficiency virus type l-infected blood donors: epidemiologic, laboratory, and donation characteristics. Transfusion 1991; 31: 698–703. 101 Gerberding JL. Does knowledge of human immunodeficiency virus infection decrease the frequency of occupational exposure to blood Am J Med 1991; 91: 308S–3US. 102 Nelsing S., Nielsen TL, Nielsen JO. Occupational blood exposure among health care workers: II. Exposure mechanisms and universal precautions. Scand J Infect Dis 1993; 25: 199–205. 103 Mast ST, Woolwine JD, Gerberding JL. Efficacy of gloves in reducing blood volumes transferred during simulated needlestick injury. J Infect Dis 1993; 168: 1589–92. 104 McGuff J., Popovsky MA. Needlestick injuries in blood collection staff: a retrospective analysis. Transfusion 1989; 29: 693–5. 105 42 USC ŝ 12101 et seq. 106 Orentlicher D. Rationing and the Americans with Disabilities Act. JAMA 1994; 271: 308–14. 107 28 CFR ŝ36.208. 108 29 USC ŝ794 el seq. 109 School Board of Nassau County Florida v. Arline 480 US ŝ273 (1987). Citing Literature Volume35, Issue4April 1995Pages 353-361 ReferencesRelatedInformation